Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxytyrosol and Vitamin E in children with NASH
NCT02842567Phase 3Completed
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydroxytyrosol and alpha-tocopherol in Nonalcoholic steatohepatitis (NASH). Primary endpoints: Tumor Necrosis Factor-alpha at 4 months and Lipopolysaccharide at 4 months. Started Apr 2017; status: completed.
02
Drugs
hydroxytyrosolalpha-tocopherol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02842567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842567.